Ischemic nephropathy/azotemic renovascular disease

Seminars in Nephrology

Volumn 20, Issue 5, 2000, Pages 489-502

  Textor, S C ^a   Wilcox, C S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN ANTAGONIST; ATENOLOL; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; METOPROLOL; NIFEDIPINE;

COMORBIDITY; FLUID RETENTION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BLOOD FLOW; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY PERFUSION; NEPHROSCLEROSIS; PRIORITY JOURNAL; RENOVASCULAR DISEASE; RENOVASCULAR HYPERTENSION; REVIEW; RISK BENEFIT ANALYSIS; UREMIA;

ALGORITHMS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; HUMANS; HYPERTENSION, RENOVASCULAR; ISCHEMIA; KIDNEY FAILURE, CHRONIC; PULMONARY EDEMA; RENAL ARTERY OBSTRUCTION; UREMIA;

EID: 0033817014     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (103)

1. Natural history of atherosclerotic and fibrous renal artery disease: Clinical implication
2. Predictors of cure of hypertension fibromuscular renovascular disease
3. AT1 receptors and TxA2/PGH2 receptors maintain hypertension throughout 2K,1C Goldblatt hypertension in the rat
4. Correction of renal hypertension in the rat by prolonged infusion of angiotensin inhibitors
5. Antihypertensive effect of prolonged blockade of angiotensin formation in benign and malignant, one- and two-kidney Goldblatt hypertensive rats
6. Sodium balance and plasma renin activity during the development of two-kidney Goldblatt hypertension in rats
7. Function of angiotenin in the central nervous system
8. Endothelial function and oxidant stress
9. Sodium and angiotensin in the pathogenesis of experimental renovascular hypertension
10. Reversal of renal hypertension: Effects on renin, salt and water balance
11. The effect of nephrectomy and adrenalectomy upon the blood pressure in hypertensive and normotensive rats
12. Use of angiotensin converting enzyme inhibitors for diagnosing renovascular hypertension
13. Critical degree of renal arterial stenosis that causes hypertension in dogs
14. Renal vein oxygen saturation in renal artery stenosis
15. Thromboxane and prostacyclin differentially regulate murine extracellular matrix gene expression
16. Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis
17. Molecular insights into renal interstitial fibrosis
18. Ischemic renal diseases: New insights into old entities
19. Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: Treatment by angioplasty or surgical revascularisation
20. Prevention of recurrent pulmonary edema in patients with bilateral renovascular disease through renal artery stent placement
21. The pathology of chronic renal ischemia
22. Ischemic obsolescence of renal glomeruli: The natural history of the lesions and their relation to hypertension
23. Glomerular expression of type III and type IV collagens in the benign nephrosclerosis: Immunohistochemical and in situ hybridization study
24. Experimental chronic renal ischemia: Morphologic and immunologic studies
25. Polyanion, immunoprotein and proteinase inhibitor in ischemic glomerular change
26. Cellular events in experimental unilateral ischemic renal atrophy and in regeneration after contralateral nephrectomy
27. Atubular glomeruli in renal artery stenosis
28. Early interstitial changes in hypertension-induced renal injury
29. Human renal vascular lesions and hypertension
30. Atheroembolic renal disease: Association with renal artery stenosis
31. Proteinuria in renovascular hypertension and the effects of renal angioplasty
32. Preliminary description of focal segmental glomerulosclerosis in patients with renovascular disease
33. Reversal of ischemic tubular atrophy
34. Temporal patterns in the medical treatment of congestive heart failure with angiotensin converting enzyme inhibitors in older adults, 1989-1995
35. Control of glomerular filtration rate by renin-angiotensin system
36. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenosis or renal-artery stenosis in a solitary kidney
37. Presentation, clinical features and outcome in different patterns of atherosclerotic renovascular disease
38. Atherosclerotic renovascular disease: Remediable cause of renal failure in the elderly
39. Renal vascular disease causing end-stage renal disease: Incidence, clinical correlates, and outcomes: A 20-year clinical experience
40. A clinical prediction rule for renal artery stenosis
41. The natural history of atherosclerotic and fibrous renal artery disease
42. Natural history of atherosclerotic renal artery stenosis associated with aortic disease
43. Prospective study of atherosclerotic disease progression in the renal artery
44. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis
45. Renovascular hypertension: Anatomic and renal functional changes during therapy
46. Advanced renovascular hypertension and renal insufficiency: Trends in medical comorbidity and surgical approach from 1970 to 1993
47. Survival in renal vascular disease
48. Reversal of end stage renal failure with surgical revascularization in patients with atherosclerotic renal artery occlusion
49. Treatment of atherosclerotic ostial renal artery stenosis with the intravascular stent
50. Critical perfusion pressure for renal function in patients with bilateral atherosclerotic renal vascular disease
51. Effect of renal-artery stenting on progression of renovascular renal failure
52. Captopril-enhanced 99TcDTPA scintigraphy in the detection of renal artery stenosis
53. Captopril radionuclide test in renovascular hypertension: A European multicentre study
54. Value of captopril renal scintigraphy in hypertensive patients with renal failure
55. Captopril renal scintigraphy in patients with hypertension and chronic renal failure
56. Furosemide-I-131-hippuran renography after angiotensin-converting enzyme inhibition for the diagnosis of renovascular hypertension
57. Post-stenotic arterial pressure, renal haemodynamics and sodium excretion during graded pressure reduction in conscious rats with one- and two-kidney coarctation hypertension
58. Pathophysiology of progressive nephropathies
59. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
60. Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril
61. The captopril GFR renogram in renovascular hypertension
62. Renal failure limiting antihypertensive therapy as an indication for renal revascularization
63. Angiotensin converting enzyme inhibitor-induced renal dysfunction in atherosclerotic renovascular disease
64. A cautious view of the value of angiotensin-converting enzyme inhibition in renovascular disease
65. Pharmacologic nephrectomy with chronic angiotensin converting enzyme inhibitor treatment in renovascular hypertension in the rat
66. Effects of antihypertensive treatment in one-clip, two kidney hypertension in rats
67. Impairment and recovery of the clipped kidney in two kidney, one clip hypertensive rats during and after antihypertensive therapy
68. Contrasting renal effects of chronic administration of enalapril and losartan on one-kidney, one-clip hypertensive rats
69. Disparate effects of Ca channel blockade on afferent and efferent arteriolar responses to ANG II
70. Adverse effect of the calcium channel blocker nitrendipine on nephrosclerosis in rats with renovascular hypertension
71. Calcium blockade versus ACE inhibition in clipped and unclipped kidneys of 2K-1C rats
72. ACE inhibition vs surgical treatment in the outcome of ischemic kidney of renovascular patients: A one year follow-up
73. Long-term monotherapy with lisinopril in renovascular hypertension
74. Medical therapy of renovascular hypertension: Efficacy and safety of captopril in 269 patients
75. Comparison of effects of enalapril plus hydrochlorothiazide versus standard triple therapy on renal function in renovascular hypertension
76. Effects of converting enzyme inhibition on split renal function in renovascular hypertension
77. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
78. Renal failure related to ACE inhibitors
79. Long-term survival after surgical revascularization for atherosclerotic renal artery disease
80. Management of renovascular disease: A surgical perspective
81. Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty
82. Ischemic nephropathy and concomitant aortic disease: A ten-year experience
83. Revascularization in atherosclerotic renal artery disease
84. Contemporary surgical management of renovascular disease
85. Short-term and long-term outcome following renovascular reconstruction
86. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis
87. Ostial renal artery stent placement for atherosclerotic renal artery stenosis in patients with coronary artery disease
88. Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty
89. Renal artery stent placement: Utility in lesions difficult to treat with balloon angioplasty
90. Treatment of atherosclerotic ostial renal artery stenosis with the intravascular stent
91. Contemporary surgical management of renovascular disease
92. Short-term and long-term outcome following renovascular reconstruction
93. Occlusive disease of the renal arteries and chronic renal failure: The limits of reconstructive surgery
94. Renal artery reconstruction for the preservation of renal function
95. Ischemic nephropathy and concomitant aortic disease: A ten-year experience
96. Changing patterns in surgery for chronic renal artery occlusive diseases
97. Renal revascularization to preserve and restore renal function
98. Critical perfusion pressure for renal function in patients with bilateral atherosclerotic renal vascular disease
99. Contrasting renal effects of chronic administration of enalapril and losartan on one-kidney, one-clip hypertensive rats
100. Effects of converting enzyme inhibition on split renal function in renovascular hypertension
101. Renal artery stent placement for the management of ischemic nephropathy
102. Outcome and cost comparison of percutaneous transluminal renal angioplasty, renal arterial stent placement, and renal arterial bypass grafting